Skip to main content
. 2016 Jul 23;7(42):68033–68043. doi: 10.18632/oncotarget.10797

Table 2. Clinical outcome in the overall series.

Characteristics LGSOC
No. of patients (%)
HGSOC
No. of patients (%)
All cases 25 55
Mean Follow up, months (range) 51 (9–180) 47 (7–140)
Clinical status
 Alive 23 (96) 22 (40)
 Alive NED 19 (76) 14 (26)
 Dead 2 (4) 33 (60)
 Recurrent (total) 5 (20) 41 (68)
  Stage I/II 1 1
  Stage III/IV 4 40

NED = No evidence of disease.